leisure time -WSS

leisure time

author：leisure time 2025-09-28 20:44:32 - browse：5821

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Health insurers' Q3 question: how much care are people getting?

focus

WSS

Clinical trials must include more disabled people

What will Novo Nordisk's VC do with its influx of cash?

CRISPR base editing slashes cholesterol levels in monkeys

Trump cancels press conference intended to dispute Georgia election interference charges

The Karikó problem: Lessons for funding basic research

Hilary may become 1st tropical storm to make landfall in California in 84 years

hotspot

leisure time

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

6 solutions to address cancer drug shortages and others

Activists slam private health insurers over coverage restrictions

European officials brace for rough respiratory virus season

Dobbs anniversary: the lost opportunity of abortion as health care

Evacuations in place as 3 wildfires burn in eastern Washington state

Psychedelics group wrestles with new pharma identity

Congress extends some pandemic preparedness programs

Hollywood unions extend contract negotiations for actors

2023 Nobel Prize in Medicine goes to Karikó and Weissman

leisure time

Majority of Americans think Trump's Ga. election interference case is serious: POLL

IVG is promising — but it won’t replace IVF quite yet

Eye stem cell transplant could help restore vision in injured people

Trump's false claims about Georgia's 2020 election long debunked

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Medicare innovation center doesn’t save money, experts say

hotspot

focus

entertainment

hotspot